Physician profile
Cary W Pulliam
NPI 1750327052
$1,303.03
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $306 · 2021: $241 · 2022: $326 · 2023: $28.73 · 2024: $19.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $48.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $48.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $558.89 | 2019-2024 | Eluvia, Varithena Administration Pack |
| Getinge USA Sales, LLC | $186.08 | 2019-2021 | |
| Organogenesis INC. | $156.86 | 2019-2022 | |
| Cardiovascular Systems INC. | $133.62 | 2019-2021 | |
| Cook Medical LLC | $115.15 | 2019-2022 | |
| Medtronic, INC. | $42.82 | 2021 | |
| Janssen Pharmaceuticals, INC | $36.75 | 2019-2022 | |
| Medtronic Vascular, INC. | $35.97 | 2019 | |
| Bard Peripheral Vascular, INC. | $25.66 | 2022 | |
| Tactile Systems Technology INC | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cary Pulliam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.